Aptima Combo 2® Assay, 100 test, box 2 of 2 (15°C to 30°C box). The Aptima Combo 2® Assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection and differentiation of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (GC) to aid in the diagnosis of chlamydial and/or gonococcal urogenital disease using the Tigris® DTS® Automated Analyzer or semi-automated instrumentation as specified.

Aptima Combo 2® Assay, 100 test, box 1 of 2 (2°C to 8°C box). The Aptima Combo 2® Assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection and differentiation of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (GC) to aid in the diagnosis of chlamydial and/or gonococcal urogenital disease using the Tigris® DTS® Automated Analyzer or semi-automated instrumentation as specified.

Aptima Combo 2® Assay, 250 test, box 2 of 2 (15°C to 30°C box). The Aptima Combo 2® Assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection and differentiation of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (GC) to aid in the diagnosis of chlamydial and/or gonococcal urogenital disease using the Tigris® DTS® Automated Analyzer or semi-automated instrumentation as specified.

Aptima Combo 2® Assay, 250 test, box 1 of 2 (2°C to 8°C box). The Aptima Combo 2® Assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection and differentiation of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (GC) to aid in the diagnosis of chlamydial and/or gonococcal urogenital disease using the Tigris® DTS® Automated Analyzer or semi-automated instrumentation as specified.

Aptima® Trichomonas vaginalis Controls Kit.

Aptima Combo 2® Assay, 100 test, box 1 of 2 (2°C to 8°C box). The Aptima Combo 2® Assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection and differentiation of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (GC) to aid in the diagnosis of chlamydial and/or gonococcal disease using the Panther® System as specified.

Aptima® CT assay, 100 test, box 1 of 2 (2°C to 8°C box). The Aptima® Chlamydia trachomatis assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) to aid in the diagnosis of chlamydial urogenital disease using the Tigris® DTS® Automated Analyzer or semi-automated instrumentation as specified.

Aptima® GC assay, 100 test, box 1 of 2 (2°C to 8°C box). The Aptima® Neisseria gonorrhoeae assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection of ribosomal RNA (rRNA) from Neisseria gonorrhoeae (GC) to aid in the diagnosis of gonococcal urogenital disease using the Tigris® DTS® System or semi-automated instrumentation as specified.

Aptima Combo 2® Assay, 100 test, box 2 of 2 (15°C to 30°C box). The Aptima Combo 2® Assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection and differentiation of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (GC) to aid in the diagnosis of chlamydial and/or gonococcal disease using the Panther® System as specified.

Aptima® CT assay, 100 test, box 2 of 2 (15°C to 30°C box). The Aptima® Chlamydia trachomatis assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) to aid in the diagnosis of chlamydial urogenital disease using the Tigris® DTS® Automated Analyzer or semi-automated instrumentation as specified.

Aptima® GC assay, 100 test, box 2 of 2 (15°C to 30°C box). The Aptima® Neisseria gonorrhoeae assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection of ribosomal RNA (rRNA) from Neisseria gonorrhoeae (GC) to aid in the diagnosis of gonococcal urogenital disease using the Tigris® DTS® System or semi-automated instrumentation as specified.

Aptima® Trichomonas vaginalis Assay, 250 test, box 1 of 2 (2°C to 8°C box). The Aptima® Trichomonas vaginalis Assay is an in vitro qualitative nucleic acid amplification test (NAAT) for the detection of ribosomal RNA (rRNA) from Trichomonas vaginalis to aid in the diagnosis of trichomoniasis using the Tigris® DTS® System.

Aptima® Trichomonas vaginalis Assay, 250 test, box 2 of 2 (15°C to 30°C box). The Aptima® Trichomonas vaginalis Assay is an in vitro qualitative nucleic acid amplification test (NAAT) for the detection of ribosomal RNA (rRNA) from Trichomonas vaginalis to aid in the diagnosis of trichomoniasis using the Tigris® DTS® System.

Aptima® Trichomonas vaginalis Assay, 100 test, box 1 of 2 (2°C to 8°C box). The Aptima® Trichomonas vaginalis Assay is an in vitro qualitative nucleic acid amplification test (NAAT) for the detection of ribosomal RNA (rRNA) from Trichomonas vaginalis to aid in the diagnosis of trichomoniasis using the Tigris® DTS® System.

Aptima® Trichomonas vaginalis Assay, 100 test, box 2 of 2 (15°C to 30°C box). The Aptima® Trichomonas vaginalis Assay is an in vitro qualitative nucleic acid amplification test (NAAT) for the detection of ribosomal RNA (rRNA) from Trichomonas vaginalis to aid in the diagnosis of trichomoniasis using the Tigris® DTS® System.

Aptima® Trichomonas vaginalis Assay, 100 test, box 2 of 2 (15°C to 30°C box). The Aptima® Trichomonas vaginalis Assay is an in vitro qualitative nucleic acid amplification test (NAAT) for the detection of ribosomal RNA (rRNA) from Trichomonas vaginalis to aid in the diagnosis of trichomoniasis using the Panther® System.

Aptima® Trichomonas vaginalis Assay, 250 test, box 2 of 2 (15°C to 30°C box). The Aptima® Trichomonas vaginalis Assay is an in vitro qualitative nucleic acid amplification test (NAAT) for the detection of ribosomal RNA (rRNA) from Trichomonas vaginalis to aid in the diagnosis of trichomoniasis using the Panther® System.

Aptima® Trichomonas vaginalis Assay, 250 test, box 1 of 2 (2°C to 8°C box). The Aptima® Trichomonas vaginalis Assay is an in vitro qualitative nucleic acid amplification test (NAAT) for the detection of ribosomal RNA (rRNA) from Trichomonas vaginalis to aid in the diagnosis of trichomoniasis using the Panther® System.

Aptima® Trichomonas vaginalis Assay, 100 test, box 1 of 2 (2°C to 8°C box). The Aptima® Trichomonas vaginalis Assay is an in vitro qualitative nucleic acid amplification test (NAAT) for the detection of ribosomal RNA (rRNA) from Trichomonas vaginalis to aid in the diagnosis of trichomoniasis using the Panther® System.

Selenia® Dimensions® digital mammography system

Selenia® Dimensions® digital mammography system

Selenia® Dimensions® digital mammography system

Selenia® Dimensions® digital mammography system

The Discovery series bone densitometers are computer-assisted X-Ray scanners used to aid a physician in measuring bone mineral density (BMD) and determining fracture risk. All Discovery Series densitometers allow comparison of estimated BMD from a subject's proximal femur (hip), lumbar spine, and forearm to reference data for sex and ethnicity matched controls. Discovery Wi, W, and A models can also be used for estimating the lean body mass and fat mass of non-osseous tissues. Discovery C, W, SL, and A models can be used for performing a visual or quantitative assessment of vertebral bodies for diagnosis of vertebral deformity. Discovery SL and A models are capable of measuring the lateral vertebral BMD in the supine lateral position.

The Discovery series bone densitometers are computer-assisted X-Ray scanners used to aid a physician in measuring bone mineral density (BMD) and determining fracture risk. All Discovery Series densitometers allow comparison of estimated BMD from a subject's proximal femur (hip), lumbar spine, and forearm to reference data for sex and ethnicity matched controls. Discovery Wi, W, and A models can also be used for estimating the lean body mass and fat mass of non-osseous tissues. Discovery C, W, SL, and A models can be used for performing a visual or quantitative assessment of vertebral bodies for diagnosis of vertebral deformity. Discovery SL and A models are capable of measuring the lateral vertebral BMD in the supine lateral position.

PRODUCT, EVIVA, 9 GA, 13 CM LENGTH, 12MM APERTURE

PRODUCT, EVIVA, 9 GA, 13 CM LENGTH, 12MM APERTURE, TROCAR

The Horizon® Dual-Energy X-Ray Absorptiometry (DXA) System is a computer-assistedX-Ray scanner used to aid a physician in measuring bone mineral density (BMD),determining fracture risk, and estimating the lean body mass and fat mass of non-osseoustissues.

The Horizon® Dual-Energy X-Ray Absorptiometry (DXA) System is a computer-assistedX-Ray scanner used to aid a physician in measuring bone mineral density (BMD),determining fracture risk, and estimating the lean body mass and fat mass of non-osseoustissues.

The Horizon® Dual-Energy X-Ray Absorptiometry (DXA) System is a computer-assistedX-Ray scanner used to aid a physician in measuring bone mineral density (BMD),determining fracture risk, and estimating the lean body mass and fat mass of non-osseoustissues.

The Horizon® Dual-Energy X-Ray Absorptiometry (DXA) System is a computer-assistedX-Ray scanner used to aid a physician in measuring bone mineral density (BMD),determining fracture risk, and estimating the lean body mass and fat mass of non-osseoustissues.

The Horizon® Dual-Energy X-Ray Absorptiometry (DXA) System is a computer-assistedX-Ray scanner used to aid a physician in measuring bone mineral density (BMD),determining fracture risk, and estimating the lean body mass and fat mass of non-osseoustissues.

The Fluoroscan InSight FD System is a mini C-Arm fluoroscopic imaging system designed to providephysicians with general fluoroscopic visualization of a patient, including, but not limited to, surgicalorthopedic and podiatry use, critical and emergency care procedures, and light anatomy imagingsituations.

Affirm Breast Biopsy Guidance System

Console used for the Trident HD system